Oracle is building open, scalable platforms so that their customers can populate them.
Pat Salber (@docweighsin) chats with Oracle’s Jonathan Sheldon (Global VP for Health Care) about meeting the data demands of Personalized (or Precision) Medicine. He says that to really unleash the power of genomics, proteomics, metabolomics and all the other -omics coming down the pike that will power truly targeted therapies, you need to be able to put the data in context. That means integrating it with the clinical, environmental, financial, operational and likely many other types of data so that we not only understand the genomics of the problem, but we understand factors that influence the expression of the genetics (aka the phenome). In this video, Jonathan describes how Oracle is building open, scalable platforms so that their customers can populate them, for later analysis, with gigantic data sets of many different types.
If you are interested in Oracle’s involvement in personalized (or precision) medicine, check out Oracle’s Health Sciences Translational Research Center for more information. There you will be able to learn just how Oracle plans to accelerate personalized medicine and genomics by putting gigantic data sets into context.
This video was filmed at the 2015 Personalized Medicine World Conference in Mountain View, California. It is under BY-ND creative commons.